Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Journal of Affective Disorders|August 27, 2019
Less memory complaints with reduced stimulus dose during electroconvulsive therapy for depressionAlexander Kronsell, Axel Nordenskjöld, Mikael TigerBMC Psychiatry|October 2, 2025
Successful treatment of five cases of catatonia treated with guanfacine without ECT: a case series from a psychiatric hospital in JapanHiroki Saito, Mikael Tiger, Ryosuke Arakawa, et al.Psychopharmacology|March 17, 2018
The 5-HT<sub>1B</sub> receptor - a potential target for antidepressant treatmentMikael Tiger, Katarina Varnäs, Yoshiro Okubo, et al.The Journal of ECT|March 19, 2026
Role of Anesthesia in ECT for Major Depressive DisorderJennifer Sjödin, Karin Zimmer, Max Bell, et al.Journal of Psychiatric Research|July 6, 2024
Long-term follow-up on patient attitudes towards renewed ECT: A register-based cohort studyAlexander Kronsell, Axel Nordenskjöld, Ellenor Mittendorfer-Rutz, et al.The International Journal of Neuropsychopharmacology|January 17, 2012
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorderJohan Lundberg, Mikael Tiger, Mikael Landén, et al.Translational Psychiatry|April 4, 2024
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemicMikael Tiger, Giulio Castelpietra, Rikke Wesselhoeft, et al.Biochemical and Biophysical Research Communications|September 11, 2004
Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activationTuire Olli-Lähdesmäki, Mikael Tiger, Minna Vainio, et al.Lakartidningen|April 4, 2024
[Psychedelic psychiatry]Evana López, Hampus Yngwe, Maria Beckman, et al.Journal of Affective Disorders|May 17, 2025
Risk of major adverse cardiovascular events in treatment-resistant or severe depressionAdam Nygren, Johan Reutfors, Pär Karlsson, et al.Pageof 4